目前已证实，几种化疗药可作为某些转移性癌症患者的新辅助治疗或辅助治疗药。
Several chemotherapeutic agents have proven to be useful as neoadjuvant or adjuvant treatment and in patients with metastatic disease.
目的：评估在局部进展期直肠癌患者中联合贝伐单抗和标准放化疗的新辅助治疗有效性和安全性，并探索标志物反应。
Purpose To assess the safety and efficacy of neoadjuvant bevacizumab with standard chemoradiotherapy in locally advanced rectal cancer and explore biomarkers for response.
新的指南中包括了教育干预、药物治疗和家庭辅助工具。
The new guidelines include educational interventions, medical care and family support tools.
应用推荐